狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當(dāng)前位置: 首頁 > ATCC代理 > Breast Cancer Biomarkers Cell Line Panel 1
最近瀏覽歷史
聯(lián)系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮(zhèn)海區(qū)莊市街道興莊路9號
  • 創(chuàng)e慧谷42號樓B幢401室
Breast Cancer Biomarkers Cell Line Panel 1
Breast Cancer Biomarkers Cell Line Panel 1
規(guī)格:
貨期:
編號:B202962
品牌:Mingzhoubio

標(biāo)準(zhǔn)菌株
定量菌液
DNA
RNA

規(guī)格:
凍干粉
斜面
甘油
平板


產(chǎn)品名稱 Breast Cancer Biomarkers Cell Line Panel 1
商品貨號 B202962
Organism Homo sapiens, human
Components
UACC-812, ATCC CRL-1897
UACC-893, ATCC CRL-1902
UACC-3199, ATCC CRL-2983
UACC-3133, ATCC CRL-2988
UACC-1179, ATCC CRL-3127
UACC-732, ATCC CRL-3166
UACC-2087, ATCC CRL-3180
Applications
Biological understanding of top genetic alterations across tumor types
Validation and characterization of potential cancer driver genes
Functional profiling and molecular profiling of subtype-specific cancer cell lines
Testing small molecules or biologics for cancer drug development
Type Strain no
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Comments
A breast cancer panel comprised of 7 early-passage tumor cell lines isolated from a variety of primary and metastatic sites, and annotated with pre-operative chemotherapy treatments and published positive and negative biomarkers. A complete listing of panel features is available as a printable PDF.
Product Format frozen 7 cryopreserved cell lines
Storage Conditions LN vapor (less than -130°C) only
梅經(jīng)理 17280875617 1438578920
胡經(jīng)理 13345964880 2438244627
周經(jīng)理 17757487661 1296385441
于經(jīng)理 18067160830 2088210172
沈經(jīng)理 19548299266 2662369050
李經(jīng)理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |